Toshiaki Iwase

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Venues

Science advances

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancers

Biomedicines

University of Texas MD Anderson Cancer Center

Chiba Daigaku Daigakuin Igaku Kenkyuin Igakubu (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas MD Anderson Cancer Center Jan 13 2017

United States

Postdoctoral Fellow :: Breast Medical Oncology-Rsch

Chiba Daigaku Apr 01 2016

Japan

Assistant Professor :: Department of General Surgery

Education History

Chiba Daigaku Daigakuin Igaku Kenkyuin Igakubu Apr 01 2013 - Mar 31 2016

Japan

PHD

Publications

Toshiaki Iwase, Evan N Cohen, Hui Gao, Angela Alexander, Megumi Kai, Vivian Chiv, Xiaoping Wang, Savitri Krishnamurthy, Diane D Liu, Yu Shen, Kumiko Kida, Alexandre Reuben, Rachel M Layman, David L Ramirez, Debasish Tripathy, Stacy L Moulder, Clinton Yam, Vicente Valero, Bora Lim, James M Reuben, Naoto Tada Ueno
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Toshiaki Iwase, Evan N Cohen, Hui Gao, Angela Alexander, Megumi Kai, Vivian Chiv, Xiaoping Wang, Savitri Krishnamurthy, Diane D Liu, Yu Shen, Kumiko Kida, Alexandre Reuben, Rachel M Layman, David L Ramirez, Debasish Tripathy, Stacy L Moulder, Clinton Yam, Vicente Valero, Bora Lim, James M Reuben, Naoto Tada Ueno
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Toshiaki Iwase, Evan N Cohen, Hui Gao, Angela Alexander, Megumi Kai, Vivian Chiv, Xiaoping Wang, Savitri Krishnamurthy, Diane D Liu, Yu Shen, Kumiko Kida, Alexandre Reuben, Rachel M Layman, David L Ramirez, Debasish Tripathy, Stacy L Moulder, Clinton Yam, Vicente Valero, Bora Lim, James M Reuben, Naoto Tada Ueno
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Toshiaki Iwase, Evan N Cohen, Hui Gao, Angela Alexander, Megumi Kai, Vivian Chiv, Xiaoping Wang, Savitri Krishnamurthy, Diane D Liu, Yu Shen, Kumiko Kida, Alexandre Reuben, Rachel M Layman, David L Ramirez, Debasish Tripathy, Stacy L Moulder, Clinton Yam, Vicente Valero, Bora Lim, James M Reuben, Naoto Tada Ueno
Maintenance pembrolizumab therapy in patients with metastatic HER2-negative breast cancer with prior response to chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Toshiaki Iwase, Evan N Cohen, Hui Gao, Angela Alexander, Megumi Kai, Vivian Chiv, Xiaoping Wang, Savitri Krishnamurthy, Diane D Liu, Yu Shen, Kumiko Kida, Alexandre Reuben, Rachel M Layman, David L Ramirez, Debasish Tripathy, Stacy L Moulder, Clinton Yam, Vicente Valero, Bora Lim, James M Reuben, Naoto Tada Ueno
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Toshiaki Iwase, Evan N Cohen, Hui Gao, Angela Alexander, Megumi Kai, Vivian Chiv, Xiaoping Wang, Savitri Krishnamurthy, Diane D Liu, Yu Shen, Kumiko Kida, Alexandre Reuben, Rachel M Layman, David L Ramirez, Debasish Tripathy, Stacy L Moulder, Clinton Yam, Vicente Valero, Bora Lim, James M Reuben, Naoto Tada Ueno
Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Dennis C Wylie, Xiaoping Wang, Jun Yao, Hengyi Xu, Elizabeth A Ferrick-Kiddie, Toshiaki Iwase, Savitri Krishnamurthy, Naoto Tada Ueno, Alan M Lambowitz
Inflammatory breast cancer biomarker identification by simultaneous TGIRT-seq profiling of coding and non-coding RNAs in tumors and blood. medRxiv : the preprint server for health sciences (2023)
Xuemei Xie, Jangsoon Lee, Jon A Fuson, Huey Liu, Toshiaki Iwase, Kyuson Yun, Cori Margain, Debasish Tripathy, Naoto Tada Ueno
Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines. Biomedicines 11 (3) (2023)
Xuemei Xie, Jangsoon Lee, Jon A Fuson, Huey Liu, Toshiaki Iwase, Kyuson Yun, Cori Margain, Debasish Tripathy, Naoto Tada Ueno
Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines. Biomedicines 11 (3) (2023)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Xiaoping Wang, Takashi Semba, Ganiraju C Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Hanh Phi, Troy Pearson, Steven J Van Laere, Jared K Burks, Evan N Cohen, James M Reuben, Fei Yang, Hu Min, Nicholas Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Batra, Yichao Shen, Xiang H F Zhang, Debasish Tripathy, Naoto Tada Ueno
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Science advances 8 (50) (2022)
Toshiaki Iwase, Kim R M Blenman, Xiaotong Li, Emily Reisenbichler, Robert Seitz, David Hout, Tyler J Nielsen, Brock L Schweitzer, Daniel B Bailey, Yichao Shen, Xiang Zhang, Lajos Pusztai, Naoto Tada Ueno
A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer. Cancers 13 (19) (2021)
Toshiaki Iwase, Tushaar Vishal Shrimanker, Ruben Rodriguez-Bautista, Onur Sahin, Anjali James, Jimin Wu, Yu Shen, Naoto Tada Ueno
Changes in Overall Survival over Time for Patients with de novo Metastatic Breast Cancer. Cancers 13 (11) (2021)
Jangsoon Lee, Huey Liu, Troy Pearson, Toshiaki Iwase, Jon Fuson, Alshad S Lalani, Lisa D Eli, Irmina Diala, Debasish Tripathy, Bora Lim, Naoto Tada Ueno
PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening. Biomedicines 9 (7) (2021)
Toshiaki Iwase, Aaroh M Parikh, Seyedeh S Dibaj, Yu Shen, Tushaar Vishal Shrimanker, Sudpreeda Chainitikun, Kumiko Kida, Maryanne E Sapon, Onur Sahin, Anjali James, Andrea Yizel Delgado Medrano, Ann H Klopp, Naoto Tada Ueno
The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy. Cancers 13 (4) (2021)
Xiaoping Wang, Takashi Semba, Lan Thi Hanh Phi, Sudpreeda Chainitikun, Toshiaki Iwase, Bora Lim, Naoto Tada Ueno
Targeting Signaling Pathways in Inflammatory Breast Cancer. Cancers 12 (9) (2020)
Toshiaki Iwase, Takafumi Sangai, Hiroshi Fujimoto, Yuji Sawabe, Kazuyuki Matsushita, Kengo Nagashima, Yasunori Sato, Ayako Nakagawa, Takahito Masuda, Takeshi Nagashima, Masayuki Ohtsuka
Quality and quantity of visceral fat tissue are associated with insulin resistance and survival outcomes after chemotherapy in patients with breast cancer. Breast cancer research and treatment 179 (2) (2019)

Toshiaki Iwase.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Toshiaki Iwase